+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Cell Culture Media And Reagents Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2021 to 2029

  • PDF Icon

    Report

  • 100 Pages
  • November 2021
  • Region: Global
  • Acute Market Reports
  • ID: 5411791
The purpose of this strategic research study titled “Cell Culture Media and Reagents Market- Growth, Future Prospects and Competitive Analysis, 2021 - 2029” is to offer industry investors, company executives, and industry participants with in-depth insights to enable them make informed strategic decisions related to the opportunities in the cell culture media and reagents market. The major target audience of this study include industry investors, cell culture media and reagents manufacturers, distributors, and institutional scholars.

Cell culture is the process in which cells are grown under controlled laboratory conditions. These cells and tissues possess several applications in the industries such as, biotechnology, pharmaceuticals and biopharmaceuticals. In addition, cell culture techniques are used in a wide range of applications that include analysis of cellular structures, regenerative medicine, research, stem cell therapy, drug discovery and development, drug manufacture, genetic engineering and others.

The key factor influencing the growth of this market is the growing importance of this technology is its use in field of conventional research as well as in development and production of essential biomolecules and therapeutics. The other key growth drivers of this market comprise rising scope of cell culture in the field of manufacturing and stem cell research, contract research, rising demand for biopharmaceuticals and artificial organ generation and shift of trend towards application of serum-free, specialty and customized media solutions. However, factors such as stringent regulatory environment, requirement of advanced manufacturing capabilities and skill sets, use of transgenic animals and plants, and ethical concerns over use of animal sources may negatively hamper the growth of this market. The prime future opportunities for the expansion of the market are growing application of cell culture in drug discovery and the recent introduction of 3D cell culture technology.

Biopharmaceuticals and therapeutics accounted for the largest market


For the purpose of this study, the cell culture media and reagents market was segmented by several applications such as biopharmaceuticals and therapeutics, regenerative medicine and tissue engineering, drug screening and drug development, cancer and other biotech research, stem cell technologies and others. In 2020, it was observed that biopharmaceuticals and therapeutics segment accounted for the largest market and stem cell technologies segment was the fastest growing segment during the forecast period 2021 - 2029. The key factors assisting the growth of biopharmaceutical and therapeutics segment is incessant research and development carried out for novel therapeutic treatments. The high growth of this segment is assisted due to rising benefits of cell culture-based vaccines coupled with mounting regulatory approvals. Moreover, the rising risk of pandemics and communicable diseases is one of the key factors driving the growth of this segment.

Asia-Pacific is expected to emerge as fastest growing regional market


Geographically, North America is the largest regional market for cell culture. In 2020, the North American cell culture media and reagents market was worth USD 3,629.7 million and is expected to reach USD 10,253.2 million in 2029, growing at a CAGR of 8.2% from 2021 to 2029. The rise in demand for automated cell culture systems and also for biologics and biosimilars are the prime factors contributing to the growth of cell culture market in North America. Favorable government policies fuelling life sciences and stem cell research will also contribute to market growth. Asia-Pacific is expected to emerge as fastest growing regional market during the forecast period, growing at CAGR of 9.9%.An increase in the number of market participants from Asia-Pacific, especially countries such as India, Japan, China and Australia and the recent trend of outsourcing research processes to emerging countries will be responsible for the growth of this market.

Key questions answered in this report

  • What are the key market segments in the current scenario and in the future by product categories?
  • What are the key market segments in the current scenario and in the future by regions?
  • What is the key impact of Covid-19 over market revenues and market determinants in the Cell Culture Media And Reagents market?
  • What are the primary and secondary macro and micro factors influencing the market growth currently and during the forecast period?
  • What are the primary and secondary macro and micro factors deterring the market growth currently and during the forecast period?
  • How to overcome the current market challenges and leverage the opportunities in each of the market segments?
  • Who are the key players in the Cell Culture Media And Reagents market and what are their key product categories and strategies?
  • What are the key strategies - mergers/acquisitions/R&D/strategic partnerships etc that companies are deploying to enhance market revenues and growth?


This product will be delivered within 2 business days.

Table of Contents

Chapter 1 Preface
1.1 Report Description
1.1.1 Purpose of the Report
1.1.2 Target Audience
1.1.3 USP and Key Offerings
1.2 Research Scope
1.3 Research Methodology
1.3.1 Phase I - Secondary Research
1.3.2 Phase II - Primary Research
1.3.3 Phase III - Expert Panel Review
1.3.4 Assumptions
Chapter 2 Executive Summary
2.1 Global Cell Culture Media and Reagents Market, by Type of Application, 2020 (USD Mn)
2.2 Global Cell Culture Media and Reagents Market, by Geography, 2020 (Value %)
Chapter 3 Global Cell Culture Media and Reagents Market Analysis
3.1 Global Cell Culture Media and Reagents Market Overview
3.2 Market Inclination Insights
3.3 Market Dynamics
3.3.1 Market Drivers
3.3.1.1 Phenomenal expansion cell culture scope across research and manufacturing
3.3.1.2 Augmenting trend of preference for customized and specialty media
3.3.1.3 Growing demand for biopharmaceuticals
3.3.2 Challenges
3.3.2.1 Regulatory stringency demanding for more sophisticated manufacturing systems
3.3.2.2 Development of alternative technologies to cell culture and ethical concerns
3.3.3 Future Prospects
3.3.3.1 Potential of 3D cell culture
3.4 Attractive Investment Proposition
3.5 Competitive Analysis of Key Market Players
Chapter 4 Global Cell Culture Media Market Analysis, by Type
4.1 Introduction
4.2 Classical Media
4.3 Lysogeny Broth
4.4 Protein-free Media
4.5 Specialty Media
4.6 Serum-free Media
4.7 Chemically-defined Media
Chapter 5 Global Cell Culture Reagents Market Analysis, by Type
5.1 Introduction
5.2 Albumin
5.2.1 Bovine Serum Albumin
5.2.2 Human Serum Albumin
5.2.3 Recombinant Human Serum Albumin
5.3 Attachment Factors
5.4 Amino Acid
5.5 Growth Factors and Cytokines
5.5.1 Tumor Necrosis Factors
5.5.2 Insulin-like Growth Factors (IGF)
5.5.3 Interferons and Interleukins
5.5.4 Others
5.6 Hormones
5.7 Other Reagents
Chapter 6 Global Cell Culture Media and Reagents Market Analysis, By Application
6.1 Overview
6.2 Biopharmaceuticals and Therapeutics
6.3 Drug Screening and Drug Development
6.4 Regenerative Medicine and Tissue Engineering
6.5 Stem Cell Technologies
6.6 Cancer and other Biotech Research
6.7 Other Applications
Chapter 7 Global Cell Culture Media and Reagents Market, By Geography
7.1 Preface
7.2 North America (U.S. & Canada)
7.3 Europe (U.K., Germany & Rest of Europe)
7.4 Asia Pacific (China, Japan, Singapore, South Korea and Rest of APAC)
7.5 Latin America (Mexico, Brazil and Rest of LATAM)
7.6 Middle East and Africa
Chapter 8 Company Profiles
8.1 Corning Life Sciences B.V.
8.1.1 Corning Life Sciences B.V.: Company Snapshot (Business Description; Financial Information; Product Position/Portfolio; News Coverage)
8.2 Becton Dickinson Company
8.2.1 Becton Dickinson Company: Company Snapshot (Business Description; Financial Information; Product Position/Portfolio; News Coverage)
8.3 Ajinomoto Co. Inc.
8.3.1 Ajinomoto Co. Inc: Company Snapshot (Business Description; Financial Information; Product Position/Portfolio; News Coverage)
8.4 EMD Millipore.
8.4.1 EMD Millipore: Company Snapshot (Business Description; Financial Information; Product Position/Portfolio; News Coverage)
8.5 Lonza Group Ltd.
8.5.1 Lonza Group Ltd. : Company Snapshot (Business Description; Financial Information; Product Position/Portfolio; News Coverage)
8.6 GE Healthcare.
8.6.1 GE Healthcare: Company Snapshot (Business Description; Financial Information; Product Position/Portfolio; News Coverage)
8.7 ALLCELLS
8.7.1 ALLCELLS: Company Snapshot (Business Description; Financial Information; Product Position/Portfolio; News Coverage)
8.8 Thermo Fisher Scientific, Inc
8.8.1 Thermo Fisher Scientific, Inc: Company Snapshot (Business Description; Financial Information; Product Position/Portfolio; News Coverage)
8.9 Sigma-Aldrich Co.LLC
8.9.1 Sigma-Aldrich Co.LLC: Company Snapshot (Business Description; Financial Information; Product Position/Portfolio; News Coverage)
8.10 VWR International, LLC

Companies Mentioned

  • Corning Life Sciences B.V.
  • Becton Dickinson Company
  • Ajinomoto Co. Inc.
  • EMD Millipore.
  • Lonza Group Ltd.
  • GE Healthcare.
  • ALLCELLS
  • Thermo Fisher Scientific Inc
  • Sigma-Aldrich Co.LLC
  • VWR International LLC